{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T16:07:44Z","timestamp":1774368464247,"version":"3.50.1"},"reference-count":51,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1673,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1111\/j.1365-2133.2010.10137.x","type":"journal-article","created":{"date-parts":[[2010,11,16]],"date-time":"2010-11-16T15:41:33Z","timestamp":1289922093000},"page":"no-no","source":"Crossref","is-referenced-by-count":16,"title":["Clinical experience of QuantiFERON\u00ae-TB Gold testing in patients with psoriasis treated with tumour necrosis factor blockers in Taiwan"],"prefix":"10.1093","author":[{"given":"H-Y.","family":"Chiu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P-R.","family":"Hsueh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T-F.","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2011,2,17]]},"reference":[{"key":"10.1111\/j.1365-2133.2010.10137.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa011110","article-title":"Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent","volume":"345","author":"Keane","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2133.2010.10137.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1002\/art.11137","article-title":"Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report","volume":"48","author":"Gomez-Reino","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2133.2010.10137.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1086\/421494","article-title":"Tuberculosis following the use of etanercept, a tumor necrosis factor inhibitor","volume":"39","author":"Mohan","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1365-2133.2010.10137.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1001\/jama.295.19.2275","article-title":"Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials","volume":"295","author":"Bongartz","year":"2006","journal-title":"JAMA"},{"key":"10.1111\/j.1365-2133.2010.10137.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/art.23705","article-title":"Effectiveness of the combination of a whole-blood interferon-gamma assay and the tuberculin skin test in detecting latent tuberculosis infection in rheumatoid arthritis patients receiving adalimumab therapy","volume":"59","author":"Chen","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2133.2010.10137.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1164\/rccm.200402-179OC","article-title":"Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens","volume":"170","author":"Mori","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1365-2133.2010.10137.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1128\/CDLI.6.4.606-609.1999","article-title":"Cellular immune responses to ESAT-6 discriminate between patients with pulmonary disease due to Mycobacterium avium complex and those with pulmonary disease due to Mycobacterium tuberculosis","volume":"6","author":"Lein","year":"1999","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1111\/j.1365-2133.2010.10137.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1093\/rheumatology\/kem064","article-title":"Use of the QuantiFERON TB Gold test as part of a screening programme in patients with RA under consideration for treatment with anti-TNF-alpha agents: the Newcastle (UK) experience","volume":"46","author":"Pratt","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1111\/j.1365-2133.2010.10137.x-BIB9|cit9","first-page":"776","article-title":"Comparison of an interferon-gamma assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population","volume":"35","author":"Ponce de Leon","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1111\/j.1365-2133.2010.10137.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/ard.2007.070789","article-title":"Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases: performance of a Mycobacterium tuberculosis antigen-specific interferon gamma assay","volume":"67","author":"Matulis","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"Suppl. 69","key":"10.1111\/j.1365-2133.2010.10137.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2133.2004.06070.x","article-title":"Biological therapies in the systemic management of psoriasis: International Consensus Conference","volume":"151","author":"Sterry","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2010.10137.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jinf.2008.02.011","article-title":"Comparison of the sensitivity and specificity of two whole blood interferon-gamma assays for M. tuberculosis infection","volume":"56","author":"Harada","year":"2008","journal-title":"J Infect"},{"key":"10.1111\/j.1365-2133.2010.10137.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1365-2133.2008.08891.x","article-title":"Tuberculosis and tumour necrosis factor-alpha inhibitor therapy: a report of three cases in patients with psoriasis. Comprehensive screening and therapeutic guidelines for clinicians","volume":"160","author":"Perlmutter","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2010.10137.x-BIB14|cit14","first-page":"14","article-title":"The status of biologic therapies in the treatment of moderate to severe psoriasis","volume":"84","author":"Menter","year":"2009","journal-title":"Cutis"},{"key":"10.1111\/j.1365-2133.2010.10137.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jaad.2008.03.023","article-title":"National Psoriasis Foundation consensus statement on screening for latent tuberculosis infection in patients with psoriasis treated with systemic and biologic agents","volume":"59","author":"Doherty","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2010.10137.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0929-6646(08)60198-9","article-title":"Extensively drug-resistant tuberculosis (XDR-TB) raises challenges in TB control in Taiwan","volume":"107","author":"Su","year":"2008","journal-title":"J Formos Med Assoc"},{"key":"10.1111\/j.1365-2133.2010.10137.x-BIB17|cit17","volume-title":"Statistics of Communicable Diseases and Surveillance Report in Taiwan Area, 2007","author":"Centers for Disease Control, Taiwan","year":"2009"},{"key":"10.1111\/j.1365-2133.2010.10137.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1111\/j.1365-2133.2008.08457.x","article-title":"QuantiFERON-TB Gold testing for tuberculosis in psoriasis patients commencing anti-tumour necrosis factor alpha therapy","volume":"158","author":"Desai","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2010.10137.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jaad.2008.05.033","article-title":"Tuberculosis in the age of biologic therapy","volume":"59","author":"Hernandez","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2010.10137.x-BIB20|cit20","first-page":"1228","article-title":"Tuberculin skin testing in BCG-vaccinated populations of adults and children at high risk for tuberculosis in Taiwan","volume":"8","author":"Bowerman","year":"2004","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1111\/j.1365-2133.2010.10137.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1136\/ard.2004.029041","article-title":"Attenuated response to purified protein derivative in patients with rheumatoid arthritis: study in a population with a high prevalence of tuberculosis","volume":"64","author":"Ponce de Leon","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1365-2133.2010.10137.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00403-009-0982-2","article-title":"Decrease in Mycobacterium tuberculosis specific immune responses in patients with untreated psoriasis living in a tuberculosis endemic area","volume":"302","author":"Silva","year":"2010","journal-title":"Arch Dermatol Res"},{"key":"10.1111\/j.1365-2133.2010.10137.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000222431","article-title":"Tuberculin skin test overestimates tuberculosis hypersensitivity in adult patients with psoriasis","volume":"219","author":"Tsiouri","year":"2009","journal-title":"Dermatology"},{"key":"10.1111\/j.1365-2133.2010.10137.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"540","DOI":"10.3122\/jabfm.2007.06.070109","article-title":"Clinical utility of interferon gamma assay in the diagnosis of tuberculosis","volume":"20","author":"Madariaga","year":"2007","journal-title":"J Am Board Fam Med"},{"key":"10.1111\/j.1365-2133.2010.10137.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/S0140-6736(06)68579-6","article-title":"Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study","volume":"367","author":"Ferrara","year":"2006","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2133.2010.10137.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1007\/s00296-007-0361-2","article-title":"Interferon gamma assay for detecting latent tuberculosis infection in rheumatoid arthritis patients during infliximab administration","volume":"27","author":"Takahashi","year":"2007","journal-title":"Rheumatol Int"},{"key":"10.1111\/j.1365-2133.2010.10137.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10238-009-0082-9","article-title":"Comparison of tuberculin skin test and QuantiFERON-TB Gold in tube test in patients with chronic inflammatory diseases living in a tuberculosis endemic population","volume":"10","author":"Gogus","year":"2010","journal-title":"Clin Exp Med"},{"key":"10.1111\/j.1365-2133.2010.10137.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1365-2133.2009.09331.x","article-title":"Tuberculosis screening in patients with psoriasis before antitumour necrosis factor therapy: comparison of an interferon-gamma release assay vs. tuberculin skin test","volume":"161","author":"Laffitte","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2010.10137.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1136\/ard.2007.069799","article-title":"Comparison of in vitro-specific blood tests with tuberculin skin test for diagnosis of latent tuberculosis before anti-TNF therapy","volume":"66","author":"Sellam","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1365-2133.2010.10137.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1164\/rccm.200502-196OC","article-title":"Routine hospital use of a new commercial whole blood interferon-gamma assay for the diagnosis of tuberculosis infection","volume":"172","author":"Ferrara","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1365-2133.2010.10137.x-BIB31|cit31","first-page":"490","article-title":"Tuberculosis morbidity in a controlled trial of the prophylactic use of isoniazid among household contacts","volume":"85","author":"Ferebee","year":"1962","journal-title":"Am Rev Respir Dis"},{"key":"10.1111\/j.1365-2133.2010.10137.x-BIB32|cit32","first-page":"847","article-title":"How much isoniazid is needed for prevention of tuberculosis among immunocompetent adults?","volume":"3","author":"Comstock","year":"1999","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1111\/j.1365-2133.2010.10137.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1002\/art.21043","article-title":"Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists","volume":"52","author":"Carmona","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2133.2010.10137.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/art.22768","article-title":"Risk of tuberculosis in patients treated with tumor necrosis factor antagonists due to incomplete prevention of reactivation of latent infection","volume":"57","author":"Gomez-Reino","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2133.2010.10137.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1164\/rccm.200711-1613OC","article-title":"Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis","volume":"177","author":"Diel","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1365-2133.2010.10137.x-BIB36|cit36","first-page":"A10","article-title":"Contact screening with single-step TIGRA testing and risk of active TB infection: the Leicester cohort analysis","volume":"64","author":"Haldar","year":"2009","journal-title":"Thorax"},{"key":"10.1111\/j.1365-2133.2010.10137.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1164\/ajrccm.175.2.198a","article-title":"Should individuals who are tuberculin skin test negative and positive to RD1-IFN-gamma assay receive preventive therapy?","volume":"175","author":"Girardi","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1365-2133.2010.10137.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1164\/rccm.200511-1783OC","article-title":"Dynamic antigen-specific T-cell responses after point-source exposure to Mycobacterium tuberculosis","volume":"174","author":"Ewer","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1365-2133.2010.10137.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1164\/rccm.200206-626OC","article-title":"Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis","volume":"167","author":"Yee","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1365-2133.2010.10137.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/j.1478-3231.2008.01700.x","article-title":"Influence of glutathione S-transferase M1 and T1 homozygous null mutations on the risk of antituberculosis drug-induced hepatotoxicity in a Caucasian population","volume":"28","author":"Leiro","year":"2008","journal-title":"Liver Int"},{"key":"10.1111\/j.1365-2133.2010.10137.x-BIB41|cit41","first-page":"994","article-title":"Drug-metabolising enzyme polymorphisms and predisposition to anti-tuberculosis drug-induced liver injury: a meta-analysis","volume":"12","author":"Sun","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1111\/j.1365-2133.2010.10137.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/17425255.3.1.1","article-title":"Genetic polymorphisms of drug-metabolizing enzymes and the susceptibility to antituberculosis drug-induced liver injury","volume":"3","author":"Huang","year":"2007","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1111\/j.1365-2133.2010.10137.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1086\/591702","article-title":"Extensively drug-resistant Mycobacterium tuberculosis during a trend of decreasing drug resistance from 2000 through 2006 at a Medical Center in Taiwan","volume":"47","author":"Lai","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1365-2133.2010.10137.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1002\/art.21382","article-title":"Tuberculosis associated with therapy against tumor necrosis factor alpha","volume":"52","author":"Winthrop","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2133.2010.10137.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1002\/art.24632","article-title":"Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: the three-year prospective French Research Axed on Tolerance of Biotherapies registry","volume":"60","author":"Tubach","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2133.2010.10137.x-BIB46|cit46","first-page":"S126","article-title":"Tuberculosis and opportunistic infections: relevance to biologic agents","volume":"22","author":"Bieber","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"10.1111\/j.1365-2133.2010.10137.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1136\/ard.2009.118935","article-title":"Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)","volume":"69","author":"Dixon","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1365-2133.2010.10137.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/art.20009","article-title":"Tuberculosis infection in patients with rheumatoid arthritis and the effect of infliximab therapy","volume":"50","author":"Wolfe","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2133.2010.10137.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/art.23210","article-title":"Is it safe to readminister tumor necrosis factor alpha antagonists following tuberculosis flare?","volume":"58","author":"Aslanidis","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2133.2010.10137.x-BIB50|cit50","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1136\/thx.2005.046797","article-title":"BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF-alpha treatment","volume":"60","author":"British Thoracic Society Standards of Care Committee","year":"2005","journal-title":"Thorax"},{"key":"10.1111\/j.1365-2133.2010.10137.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1136\/ard.62.8.791","article-title":"French guidelines for diagnosis and treating latent and active tuberculosis in patients with RA treated with TNF blockers","volume":"62","author":"Mariette","year":"2003","journal-title":"Ann Rheum Dis"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2010.10137.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2010.10137.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T13:50:44Z","timestamp":1676382644000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/164\/3\/553\/6643988"}},"subtitle":["QuantiFERON\u00ae-TB Gold testing in psoriasis patients on TNF blockers"],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":51,"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2010.10137.x","relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]}}}